Eclipse Ingredients uses precision fermentation to bio-manufacture high-value health ingredients, starting with human lactoferrin. This scalable biotechnological approach makes scarce compounds more accessible for nutraceutical, functional food, and dietary supplement industries.
Funding
$4.6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
- Startup funding source · Source unavailable
Founders
Product
Problem
The production of certain high-value health ingredients, such as human lactoferrin, is limited by natural scarcity and complex extraction processes. This scarcity restricts their widespread availability and application in enhancing human wellbeing across various life stages.
Solution
Eclipse Ingredients employs precision fermentation to produce premium health ingredients, beginning with human lactoferrin. This biotechnological approach enables the scalable synthesis of compounds that are otherwise difficult to obtain. By leveraging microbial hosts, the company can efficiently manufacture these valuable molecules, making them more accessible for use in health and wellness products. This platform technology is designed for continuous innovation, allowing for the development of a pipeline of novel ingredients.
Target Audience
Eclipse Ingredients targets B2B customers in the nutraceutical, functional food, and dietary supplement industries seeking high-quality, sustainably produced health ingredients.
Features
- Precision fermentation platform for the bio-manufacturing of complex health ingredients.
- Focus on producing human lactoferrin, a protein with significant health benefits.
- Proprietary microbial strains engineered for high-yield protein expression.
- Downstream processing capabilities to ensure ingredient purity and quality.
- Modular platform designed to accelerate the development of new ingredient candidates.